• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰头癌门静脉侵犯的临床意义。

Clinical significance of portal invasion by pancreatic head carcinoma.

作者信息

Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H

机构信息

Department of Surgery II, Nagoya University School of Medicine, Japan.

出版信息

Surgery. 1995 Jan;117(1):50-5. doi: 10.1016/s0039-6060(05)80229-6.

DOI:10.1016/s0039-6060(05)80229-6
PMID:7809836
Abstract

BACKGROUND

The purpose of the present study was to clarify the indication of aggressive surgery for pancreatic head carcinoma.

METHODS

Laparatomy was performed in 153 patients with carcinoma, 101 of whom underwent resection of the carcinoma. With histologic examination the degree of carcinoma invasion into the portal vein was classified into grades 0, I, or II according to the depth of invasion by the carcinoma. Macroscopic carcinoma invasion into portal vein was classified into types A, B, C, or D according to preoperative findings on the portal phase of superior mesenteric angiography or intraoperative portography.

RESULTS

Macroscopic findings correlated with the histologic invasion grades. The 1-year survival rate was 39.6% in grade 0, 11.3% in grade I, and 5.5% in grade II cases. The survival rates of patients with type A (p < 0.01), B (p < 0.05), and C invasion (p < 0.01) were higher than those of patients who did not undergo resection; however, no significant difference in the survival rates between patients who did not undergo resection and patients with type D invasion was observed.

CONCLUSIONS

For locally advanced carcinoma of the pancreatic head or entire pancreas, patients with type D invasion have no indication of aggressive surgery.

摘要

背景

本研究的目的是明确胰头癌根治性手术的指征。

方法

对153例胰腺癌患者实施了剖腹手术,其中101例行癌切除术。通过组织学检查,根据癌浸润门静脉的深度将癌浸润程度分为0级、I级或II级。根据术前肠系膜上动脉造影门静脉期或术中门静脉造影的表现,将肉眼可见的癌浸润门静脉分为A、B、C或D型。

结果

肉眼所见与组织学浸润分级相关。0级患者1年生存率为39.6%,I级为11.3%,II级为5.5%。A(p < 0.01)、B(p < 0.05)和C型浸润(p < 0.01)患者的生存率高于未行切除术的患者;然而,未行切除术的患者与D型浸润患者的生存率之间未观察到显著差异。

结论

对于局部进展期胰头癌或全胰腺癌,D型浸润患者无根治性手术指征。

相似文献

1
Clinical significance of portal invasion by pancreatic head carcinoma.胰头癌门静脉侵犯的临床意义。
Surgery. 1995 Jan;117(1):50-5. doi: 10.1016/s0039-6060(05)80229-6.
2
Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.胰腺癌门静脉壁侵犯的影像学分类与病理学分级的相关性。
Ann Surg. 2012 Jan;255(1):103-8. doi: 10.1097/SLA.0b013e318237872e.
3
Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.胰头腺癌门静脉肠系膜静脉侵犯的长期预后及预后因素
ANZ J Surg. 2015 Apr;85(4):264-9. doi: 10.1111/ans.12502. Epub 2014 Feb 12.
4
[En bloc vein resection in the treatment of pancreatic tumors adherent to the superior mesenteric-portal vein confluence].整块静脉切除治疗累及肠系膜上静脉-门静脉汇合处的胰腺肿瘤
Zhonghua Wai Ke Za Zhi. 1997 Mar;35(3):144-6.
5
Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.胰腺癌:吉隆坡大学医院的切除结果
Int Surg. 1997 Jul-Sep;82(3):269-74.
6
Combined resection of the portal vein for pancreatic cancer: preoperative diagnosis of invasion by portography and prognosis.
Hepatogastroenterology. 2000 Mar-Apr;47(32):545-9.
7
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.胰腺导管腺癌根治性切除术后的长期生存。5年生存者的临床病理分析。
Ann Surg. 1996 Mar;223(3):273-9. doi: 10.1097/00000658-199603000-00007.
8
Isolated pancreatectomy for ductal carcinoma of the head of the pancreas.针对胰腺头部导管癌的孤立性胰腺切除术。
Hepatogastroenterology. 1994 Oct;41(5):483-8.
9
Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.重新评估门静脉-肠系膜上静脉侵犯在临界可切除胰腺癌中的临床意义。
Eur J Surg Oncol. 2017 Jun;43(6):1068-1075. doi: 10.1016/j.ejso.2017.03.020. Epub 2017 Apr 8.
10
Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.胰腺癌根治性切除术后门静脉壁侵犯深度的意义
Arch Surg. 2007 Feb;142(2):172-9; discussion 180. doi: 10.1001/archsurg.142.2.172.

引用本文的文献

1
Curative intent treatment for pancreatic duct adenocarcinoma invade superior mesenteric vein.针对侵犯肠系膜上静脉的胰腺导管腺癌的根治性治疗。
Radiol Case Rep. 2024 Sep 24;19(12):6265-6268. doi: 10.1016/j.radcr.2024.09.033. eCollection 2024 Dec.
2
Reappraisal of the current resectability criteria and optimal treatment strategies for pancreatic cancer.重新评估胰腺癌当前的可切除性标准及最佳治疗策略。
J Gastrointest Oncol. 2024 Jun 30;15(3):1245-1254. doi: 10.21037/jgo-24-102. Epub 2024 Jun 21.
3
Impact of Portal Vein Resection (PVR) in Patients Who Underwent Curative Intended Pancreatic Head Resection.
门静脉切除(PVR)对接受根治性胰头切除术患者的影响。
Biomedicines. 2023 Nov 11;11(11):3025. doi: 10.3390/biomedicines11113025.
4
Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection.胰腺癌的外科治疗:血管切除的当前争议性话题。
Cancer Control. 2023 Jan-Dec;30:10732748231153094. doi: 10.1177/10732748231153094.
5
Isolated pancreatectomy using mesenteric approach.肠系膜入路的孤立性胰腺切除术。
J Hepatobiliary Pancreat Sci. 2022 Mar;29(3):293-300. doi: 10.1002/jhbp.1092. Epub 2021 Dec 21.
6
Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy.新辅助治疗时代的可切除边缘胰腺癌与血管切除术
World J Clin Cases. 2021 Jul 16;9(20):5398-5407. doi: 10.12998/wjcc.v9.i20.5398.
7
Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment.基于日本解剖学分类对多模式治疗时代可切除胰头癌合适解剖范围的重新考量
Cancers (Basel). 2021 Jul 19;13(14):3605. doi: 10.3390/cancers13143605.
8
Colonic varices treated with embolization after pancreatoduodenectomy with portal vein resection: a case report.胰十二指肠切除联合门静脉切除术后经栓塞治疗的结肠静脉曲张:一例报告
Surg Case Rep. 2020 Jun 3;6(1):126. doi: 10.1186/s40792-020-00888-9.
9
Pathology of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications.治疗后胰腺导管腺癌的病理学及其临床意义。
Arch Pathol Lab Med. 2020 Jul 1;144(7):838-845. doi: 10.5858/arpa.2019-0477-RA.
10
Pancreatoduodenectomy with portal vein resection favors the survival time of patients with pancreatic ductal adenocarcinoma: A propensity score matching analysis.门静脉切除的胰十二指肠切除术有利于胰腺导管腺癌患者的生存时间:一项倾向评分匹配分析。
Oncol Lett. 2019 Nov;18(5):4563-4572. doi: 10.3892/ol.2019.10822. Epub 2019 Sep 6.